Tech
AstraZeneca Messes Up Again, Called Out for Using Old Data in U.S. Trial Results
Pharmaceutical company AstraZeneca isn’t running out of rakes to step on anytime soon. Less than a day after the company announced promising preliminary results from the U.S. trial of its covid-19 vaccine jointly developed with Oxford University, an independent panel of scientists monitoring the study issued a harsh…
